Results 111 to 120 of about 44,168 (180)

CHRNB4-Mediated Neuroactive Signaling Rewiring Drives Adaptive Resistance to BCL-2 Inhibition in Acute Myeloid Leukemia. [PDF]

Cancers (Basel)
Koyama H, Seo S, Tse W, Bian S, Liu S.
europepmc   +1 more source

CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients. [PDF]

Blood Cancer J
Fathima S, Rokach L, Ghosoun N, Rezasoltani M, Ilyas R, Alsugair A, McCullough K, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Mangaonkar AA, Matin A, Saliba AN, Hefazi Torghabeh M, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Palmer J, Punwani N, Sproat L, Khera N, Arana Yi C, Tefferi A, Gangat N.   +29 more
europepmc   +1 more source

A practical, low-cost floating flux chamber for measuring greenhouse gas emissions from small urban waterbodies. [PDF]

Environ Monit Assess
Reynolds BE, Van De Ven CJC, Heyes E, Drake J.   +3 more
europepmc   +1 more source

Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience. [PDF]

EJHaem
Heyman B, Choi M, Kipps TJ.
europepmc   +1 more source

Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting. [PDF]

Blood Adv
Da Ros A, Peloso A, Longo G, Benetton M, Indio V, Cairo S, Sandri M, Buldini B, Bresolin S, Rosato A, Pession A, Tregnago C, Locatelli F, Pigazzi M.   +13 more
europepmc   +1 more source

Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group. [PDF]

Bone Marrow Transplant
Tauveron-Jalenques U, Aspas Requena G, Gross Z, Tavernier E, Chorão P, Carre M, Cornillon J, Contejean A, Santana C, Rocher C, Lamure S, Mauz N, Thevenet U, Boullanger N, Pica GM, Dony A, Michallet M, Belhabri A, Heiblig M.   +18 more
europepmc   +1 more source

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors. [PDF]

Ann Hematol
Jovein MM, Meyer T, Waterhouse M, Pfeifer D, Duque-Afonso J, Lübbert M, Maas-Bauer K, Wäsch R, Bertz H, Duyster J, Zeiser R, Finke J, Wehr C.   +12 more
europepmc   +1 more source

Author Correction: Isolation and proteomic analysis of the SYP61 compartment reveal its role in exocytic trafficking in Arabidopsis. [PDF]

Cell Res
Drakakaki G, van de Ven W, Pan S, Miao Y, Wang J, Keinath NF, Weatherly B, Jiang L, Schumacher K, Hicks G, Raikhel N.   +10 more
europepmc   +1 more source

Venetoclax combined with chidamide and decitabine successfully induced remission in relapsed/refractory classical Hodgkin lymphoma: a case report and literature review. [PDF]

Front Immunol
Jin X, Tang Y, Wu Y, Ji J.
europepmc   +1 more source